Moreover, CASC9 serves as an oncogene in multiple tumors, including CRC,22 bladder cancer,23 and papillary thyroid cancer.24 The relationship between HOXC-AS2 and digestive cancers remains unclear. Here, CASC9 is linked to urinary bladder carcinoma.